These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24923360)

  • 1. Hologram quantitative structure activity relationship, docking, and molecular dynamics studies of inhibitors for CXCR4.
    Zhang C; Du C; Feng Z; Zhu J; Li Y
    Chem Biol Drug Des; 2015 Feb; 85(2):119-36. PubMed ID: 24923360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure.
    Cox BD; Prosser AR; Katzman BM; Alcaraz AA; Liotta DC; Wilson LJ; Snyder JP
    Chembiochem; 2014 Jul; 15(11):1614-20. PubMed ID: 24990206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based development of antagonists for chemokine receptor CXCR4.
    Zhang C; Hou T; Feng Z; Li Y
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):60-75. PubMed ID: 22734712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.
    Johnson VA; Cramer YS; Rosenkranz SL; Becker S; Klingman KL; Kallungal B; Coakley E; Acosta EP; Calandra G; Saag MS;
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):691-697. PubMed ID: 31099252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor.
    Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
    J Mol Graph Model; 2015 Jul; 60():1-14. PubMed ID: 26080355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor.
    Mosi RM; Anastassova V; Cox J; Darkes MC; Idzan SR; Labrecque J; Lau G; Nelson KL; Patel K; Santucci Z; Wong RS; Skerlj RT; Bridger GJ; Huskens D; Schols D; Fricker SP
    Biochem Pharmacol; 2012 Feb; 83(4):472-9. PubMed ID: 22146583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors.
    Das D; Maeda K; Hayashi Y; Gavande N; Desai DV; Chang SB; Ghosh AK; Mitsuya H
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1895-904. PubMed ID: 25583709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1.
    Gudmundsson KS; Sebahar PR; Richardson LD; Miller JF; Turner EM; Catalano JG; Spaltenstein A; Lawrence W; Thomson M; Jenkinson S
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5048-52. PubMed ID: 19640718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists.
    Kawatkar SP; Yan M; Gevariya H; Lim MY; Eisold S; Zhu X; Huang Z; An J
    Exp Biol Med (Maywood); 2011 Jul; 236(7):844-50. PubMed ID: 21697335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.
    Wong RS; Bodart V; Metz M; Labrecque J; Bridger G; Fricker SP
    Mol Pharmacol; 2008 Dec; 74(6):1485-95. PubMed ID: 18768385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.
    Skerlj RT; Bridger GJ; Kaller A; McEachern EJ; Crawford JB; Zhou Y; Atsma B; Langille J; Nan S; Veale D; Wilson T; Harwig C; Hatse S; Princen K; De Clercq E; Schols D
    J Med Chem; 2010 Apr; 53(8):3376-88. PubMed ID: 20297846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection.
    Wilkinson RA; Pincus SH; Song K; Shepard JB; Weaver AJ; Labib ME; Teintze M
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2197-201. PubMed ID: 23434419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication.
    Skerlj R; Bridger G; McEachern E; Harwig C; Smith C; Wilson T; Veale D; Yee H; Crawford J; Skupinska K; Wauthy R; Yang W; Zhu Y; Bogucki D; Di Fluri M; Langille J; Huskens D; De Clercq E; Schols D
    Bioorg Med Chem Lett; 2011 Jan; 21(1):262-6. PubMed ID: 21109432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway and mechanism of drug binding to chemokine receptors revealed by accelerated molecular simulations.
    Pawnikar S; Miao Y
    Future Med Chem; 2020 Jul; 12(13):1213-1225. PubMed ID: 32515227
    [No Abstract]   [Full Text] [Related]  

  • 16. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands.
    Sakyiamah MM; Kobayakawa T; Fujino M; Konno M; Narumi T; Tanaka T; Nomura W; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2019 Mar; 27(6):1130-1138. PubMed ID: 30772128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.
    Seibert C; Sakmar TP
    Curr Pharm Des; 2004; 10(17):2041-62. PubMed ID: 15279544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development.
    Singh S; Malik BK; Sharma DK
    Chem Biol Drug Des; 2007 Mar; 69(3):191-203. PubMed ID: 17441905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors.
    Van Hout A; D'huys T; Oeyen M; Schols D; Van Loy T
    PLoS One; 2017; 12(4):e0176057. PubMed ID: 28410420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.